Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
79 hedge funds and large institutions have $276M invested in Syneron Medical Ltd in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 12 closing their positions.
998% more call options, than puts
Call options by funds: $516K | Put options by funds: $47K
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 80 → 79 (-1)
13% less capital invested
Capital invested by funds: $319M → $276M (-$42.7M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$15.8M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.71M |
| 3 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$2.2M |
| 4 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$1.56M |
| 5 |
Renaissance Technologies
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$10.5M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$3.46M |
| 3 |
RA
Royce & Associates
New York
|
-$1.46M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$959K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$958K |
ELOS Hedge Fund Activity: Q2 2015 in Review
79 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2015, worth a combined $276M — down 13% from $319M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ELOS and 11 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 23 added.
The largest buyer was Deerfield Management, adding an estimated $15.8M. The largest seller was Visium Asset Management, cutting an estimated $10.5M.
- 79 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2015, down from 80 in Q1 2015.
- Funds reported $276M of Syneron Medical Ltd stock for Q2 2015, down 13% quarter-over-quarter.
- 11 funds opened new Syneron Medical Ltd positions in Q2 2015 and 12 closed out, a net change of -1 holder.
- The largest Syneron Medical Ltd buyer in Q2 2015 was Deerfield Management, an estimated $15.8M added.
- The largest Syneron Medical Ltd seller in Q2 2015 was Visium Asset Management, an estimated $10.5M sold.
Based on aggregated 13F filings for Q2 2015.